Sidhivinayak taimes Shimla Chandigarh, 12 January 2026: The Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, has taken a major step in advancing India’s medical technology sector by signing a landmark Transfer of Technology agreement with Clarity Medical Pvt. Ltd., Mohali, for the indigenously developed “TrueOxy+ High Flow Nasal Cannula (HFNC) Device.” Developed under a Department of Science and Technology-supported research project, TrueOxy+ is designed to provide a cost-effective, high-quality solution for patients with acute hypoxemic respiratory failure and related conditions, meeting international safety and clinical standards. The device, developed between 2021 and 2024 under the leadership of Prof. G.D. Puri, features precise automatic control of flow rates up to 60 litres per minute, adjustable oxygen concentration from 21% to 100%, integrated monitoring, and advanced patient-safety features. After rigorous testing and Phase 1 clinical trials at PGIMER, the device has been undergoing Phase 2 trials and is now ready for large-scale production. With this partnership, Clarity Medical Pvt. Ltd. will oversee manufacturing, regulatory approvals, and product scale-up, ensuring that TrueOxy+ is widely available at an affordable price. Speaking at the technology transfer ceremony, Prof. Vivek Lal, Director of PGIMER, highlighted the importance of developing indigenous medical technologies to reduce dependence on imports and strengthen India’s self-reliant critical care ecosystem.
Senior officials from PGIMER and Clarity Medical, including project investigators Prof. G.D. Puri and Dr. Shiv Lal Soni, attended the event, praising the collaborative effort that began during the COVID-19 pandemic. TrueOxy+ is expected to significantly improve respiratory care in hospitals across India, with applications ranging from ICU support to post-operative recovery, non-operating room anesthesia, and monitored anesthesia procedures. The successful transfer of this technology underscores India’s growing capacity to innovate and manufacture world-class medical devices domestically, advancing the vision of “Make in India” and “Atmanirbhar Bharat” in healthcare.
Loading ...
